Work

Enhanced Safety and Antitumor Efficacy of Switchable Dual Chimeric Antigen Receptor-Engineered T Cells against Solid Tumors through a Synthetic Bifunctional PD-L1-Blocking Peptide

Year: 2020

Type: article

Source: Journal of the American Chemical Society

DOI: 10.1021/jacs.0c08538

Authors: Peiwei Yang, Ying Wang, Zheng Yao, Xinmei Gao, Chen Liu, Xinmin Wang, Heming Wu, Xu Ding, Jialiang Hu, Bingjing Lin, Qian Li, Mengwei Li, Xin Li, Xiangying Chen, Weiyan Qi, Weiguang Li, Jianpeng Xue, Hanmei Xu

Institutions: China Pharmaceutical University, State Key Laboratory of Natural Medicine

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Ministry of Education of the People's Republic of China, Ministry of Science and Technology of the People's Republic of China, Natural Science Foundation of Jiangsu Province, State Key Laboratory of Natural Medicines, Priority Academic Program Development of Jiangsu Higher Education Institutions

Awards: G1539536229, G2460542752, G2951836934, G6282567439, G6929776402, G7226827452, G7722930932, G8735027995

OpenAlex ID: W3088009365

FWCI: 1.354

Cites: 39

Cited by: 27

Related to: 10